Kastamonu Medical Journal regularly publishes internationally qualified issues in the field of Medicine in the light of up-to-date information.

EndNote Style
Original Article
Comparison of detailed brain volume measurements in schizophrenia with healthy individuals
Aims: This study aims to provide insights into the preliminary and definitive diagnosis, treatment modalities, and elucidation of the underlying pathophysiological mechanisms of schizophrenia, alongside ongoing research efforts.
Methods: This retrospective study examined a cohort of 31 patients (17 male, 14 female) diagnosed with schizophrenia according to the criteria specified in the Diagnostic and Statistical Manual of Mental Disorders (DSM V) at the Psychiatry Clinic of the University Hospital. The healthy control group, comprising 31 individuals (17 male, 14 female), was selected from archived records at the same hospital, with sociodemographic characteristics matching those of the patient group. High-resolution T1-weighted MRI images of the individuals were analyzed using the VolBrain AssemblyNet program.
Results: It has been observed that the volumes of various brain structures, including white matter (WM), gray matter (GM), subcortical GM, cortical GM, WM+GM, IC, total cerebrum, right cerebrum, left cerebrum, cerebrum WM, cerebrum GM, are significantly reduced (p<0.05) in patients diagnosed with schizophrenia compared to healthy controls. Additionally, volumes of cerebellar WM, GM, vermis, brainstem, accumbens, hippocampus, thalamus, ventral diencephalon (DC), amygdala, and basal forebrain were found to be decreased in schizophrenia patients compared to healthy controls. Conversely, volumes of the pallidum, caudate, putamen, inferior lateral ventricle, lateral ventricle, third ventricle, fourth ventricle, and CSF were observed to be increased.
Conclusion: These findings underscore the widespread nature of neuroanatomical alterations in schizophrenia and highlight the importance of understanding these changes for elucidating the disorder's pathophysiology and developing targeted therapeutic interventions. Further research is warranted to explore the interplay of genetic, developmental, and environmental factors in schizophrenia.

1. Dong M, Lu L, Zhang L, et al. Quality of life in schizophrenia: a meta-analysis of comparative studies. Psychiatr Q. 2019;90(3):519-532.
2. Green MF, Harvey PD. Cognition in schizophrenia: past, present, andfuture. Schizophr Res Cogn. 2014;1(1):e1-e9.
3. Kuo SS, Pogue-Geile MF. Variation in fourteen brain structure volumesin schizophrenia: a comprehensive meta-analysis of 246 studies. NeurosciBiobehav Rev. 2019;98:85-94.
4. Deniz G, Karakurt N, &Ouml;zcan H, Niyazi A. Comparison of brain volumemeasurements in methamphetamine use disorder with healthy individualsusing volbrain method. Adıyaman &Uuml;niv Sağ Bil Derg. 2023;9(3):188-198.
5. Shen CL, Tsai SJ, Lin CP, Yang AC. Progressive brain abnormalities inschizophrenia across different illness periods: a structural and functionalMRI study. Schizophr. 2023;9(1):2.
6. Wu C, Ferreira F, Fox M, et al. Clinical applications of magnetic resonanceimaging based functional and structural connectivity. Neuroimage.2021;244:118649.
7. Wang YM, Wang Y, Cao Q, Zhang M. Aberrant brain structure in patientswith schizophrenia and violence: a meta-analysis. J Psychiatr Res. 2023;164:447-453.
8. George D. SPSS for windows step by step: a simple study guide andreference, 17.0 update, 10/e. Pearson Education India. 2011.
9. Suzuki M, Nohara S, Hagino H, et al. Regional changes in brain gray andwhite matter in patients with schizophrenia demonstrated with voxel-based analysis of MRI. Schizophr Res. 2002;55(1-2):41-54.
10. Tamagaki C, Sedvall GC, J&ouml;nsson EG, et al. Altered white matter/graymatter proportions in the striatum of patients with schizophrenia: avolumetric MRI study. Am J Psychiatry. 2005;162(12):2315-2321.
11. Makris N, Seidman LJ, Ahern T, et al. White matter volume abnormalitiesand associations with symptomatology in schizophrenia. Psychiatry Res.2010;183(1):21-29.
12. Vitolo E, Tatu MK, Pignolo C, Cauda F, Costa T, Zennaro A. White matter andschizophrenia: a meta-analysis of voxel-based morphometry and diffusiontensor imaging studies. Psychiatry Res Neuroimaging. 2017;270:8-21.
13. Kim GW, Jeong GW. White matter volume change and its correlation withsymptom severity in patients with schizophrenia: a VBM-DARTEL study.Neuroreport. 2015;26(18):1095-1100.
14. Zhang Y, Catts V, Sheedy D, McCrossin T, Kril J, Shannon Weickert C.Cortical grey matter volume reduction in people with schizophrenia isassociated with neuro-inflammation. Translat Psychiatry. 2016;6(12):e982-e982.
15. Zhang X, Zhang Y, Liao J, et al. Progressive grey matter volume changes inpatients with schizophrenia over 6 weeks of antipsychotic treatment and theirrelationship to clinical improvement. Neurosci Bull. 2018;34(5):816-826.
16. Stegmayer K, Horn H, Federspiel A, et al. Ventral striatum gray matterdensity reduction in patients with schizophrenia and psychotic emotionaldysregulation. Neuroimage Clin. 2014;4:232-239.
17. Gur RE, Turetsky BI, Bilker WB, Gur RC. Reduced gray matter volume inschizophrenia. Arch Gen Psychiatry. 1999;56(10):905-911.
18. Hulshoff Pol HE, Schnack HG, Bertens MG, et al. Volume changes in graymatter in patients with schizophrenia. Am J Psychiatry. 2002;159(2):244-250.
19. Haijma SV, Van Haren N, Cahn W, Koolschijn PCM, Hulshoff Pol HE,Kahn RS. Brain volumes in schizophrenia: a meta-analysis in over 18 000subjects. Schizophr Bull. 2013;39(5):1129-1138.
20. Laidi C, d&rsquo;Albis MA, Wessa M, et al. Cerebellar volume in schizophreniaand bipolar I disorder with and without psychotic features. Acta PsychiatrScand. 2015;131(3):223-233.
21. &Ouml;zbek A, G&ouml;&ccedil;men Mas N, Turan S, et al. Cerebellar volume in early-onsetschizophrenia and its association with severity of symptoms. J Int Med Res.2019;47(1):411-419.
22. Fritze S, Thieme CE, Kubera KM, et al. Brainstem alterations contributeto catatonia in schizophrenia spectrum disorders. Schizophr Res. 2020;224:82-87.
23. Bois C, Levita L, Ripp I, et al. Hippocampal, amygdala and nucleusaccumbens volume in first-episode schizophrenia patients and individualsat high familial risk: a cross-sectional comparison. Schizophr Res. 2015;165(1):45-51.
24. Nakahara S, Matsumoto M, van Erp TG. Hippocampal subregionabnormalities in schizophrenia: a systematic review of structural andphysiological imaging studies. Neuropsychopharmacol Rep. 2018;38(4):156-166.
25. Pergola G, Selvaggi P, Trizio S, Bertolino A, Blasi G. The role of thethalamus in schizophrenia from a neuroimaging perspective. NeurosciBiobehav Rev. 2015;54:57-75.
26. Tognin S, Rambaldelli G, Perlini C, et al. Enlarged hypothalamic volumesin schizophrenia. Psychiatry Res. 2012;204(2-3):75-81.
27. Koolschijn PCM, van Haren NE, Pol HEH, Kahn RS. Hypothalamus volumein twin pairs discordant for schizophrenia. Eur Neuropsychopharmacol.2008;18(4):312-315.
28. Klomp A, Koolschijn PCM, Hulshoff Pol HE, Kahn RS, Van Haren NE.Hypothalamus and pituitary volume in schizophrenia: a structural MRIstudy. Int J Neuropsychopharmacol. 2012;15(2):281-288.
29. Mamah D, Wang L, Barch D, de Erausquin GA, Gado M, Csernansky JG.Structural analysis of the basal ganglia in schizophrenia. Schizophr Res.2007;89(1-3):59-71.
30. Okada N, Fukunaga M, Yamashita F, et al. Abnormal asymmetriesin subcortical brain volume in schizophrenia. Mol Psychiatry. 2016;21(10):1460-1466.
31. Svancer P, Spaniel F. Brain ventricular volume changes in schizophrenia. Anarrative review. Neurosci Lett. 2021;759:136065.
32. Kempton MJ, Stahl D, Williams SC, DeLisi LE. Progressive lateralventricular enlargement in schizophrenia: a meta-analysis of longitudinalMRI studies. Schizophr Res. 2010;120(1-3):54-62.
Volume 4, Issue 2, 2024
Page : 52-61